Celularity Receives $10M in Financing from DoubleLine Capital LP
ByAinvest
Tuesday, Dec 23, 2025 4:20 pm ET1min read
CELU--
Celularity Inc., a regenerative and cellular medicine company, has closed a financing transaction with Philip A. Barach, co-founder and former president of DoubleLine Capital LP. The transaction provides Celularity with $10 million in gross proceeds and the potential for an additional $2 million, subject to specified conditions. The financing includes a senior secured term loan and a secured convertible note, and is intended to support Celularity's ongoing operations and strategic initiatives.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet